title: [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
abstract: The aim of osteoporosis treatment is to reduce fracture risk. Many kinds of anti-osteoporosis drugs are available in these days, and most of them increase bone mineral density and reduce the risk of fractures. Japanese 2011 guidelines for prevention and treatment of osteoporosis documents the recommendation level of each osteoporosis drugs. It is important to select drugs appropriate for each osteoporosis patient considering the mechanisms of drug action and their clinical efficiency.
authors.affiliation: Department of Orthopaedic Surgery, The University of Tokyo Hospital, Japan.
authors.forename: Kumiko
authors.initials: K
authors.lastname: Ono
authors.forename: Satoru
authors.initials: S
authors.lastname: Ohashi
authors.forename: Sakae
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002762:Cholecalciferol / Q000008:administration & dosage*; D000069448:Denosumab; D004164:Diphosphonates / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D000077557:Ibandronic Acid; D058990:Molecular Targeted Therapy; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control; D019379:Teriparatide / Q000008:administration & dosage
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D019379:Teriparatide; D002762:Cholecalciferol; D000069448:Denosumab; D020849:Raloxifene Hydrochloride; D000077557:Ibandronic Acid